CORT Live signals | Maximize Profits with Getagraph.com

SELL 102723 min ago

@ $23.28

Issued: 14 Feb 2024 @ 09:30

Return: -4.60%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: 0.28 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States...

Stats
Today's Volume	1.16M
Average Volume	1.18M
Market Cap	2.30B
EPS	$0 ( 2024-02-15 )
Next earnings date	( $0.180 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	23.63
ATR14	$0.0190 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Mahoney David L	Buy	27 806	Common Stock
2024-04-10	Mahoney David L	Buy	30 000	Common Stock
2024-04-10	Mahoney David L	Sell	2 194	Common Stock
2024-04-10	Mahoney David L	Sell	27 806	Common Stock
2024-04-10	Mahoney David L	Sell	30 000	Stock option (right to buy)

INSIDER POWER
62.30
Last 97 transactions
Buy: 1 925 494 \| Sell: 448 997

Volume Correlation

Long: 0.15 (neutral)

Short: 0.59 (weak)

Signal:(61.148) Neutral

Corcept Therapeutics Inc Correlation

10 Most Positive Correlations
SVAC	0.941
PAIC	0.916
TLGT	0.913
GETVV	0.897
RMRM	0.897
SVOK	0.891
MTSL	0.888
CERC	0.865
GOODM	0.854
FCFS	0.838

10 Most Negative Correlations
AMRB	-0.968
NETE	-0.941
MMAC	-0.919
PFG	-0.901
LINC	-0.887
FFBW	-0.872
SRAC	-0.871
REG	-0.865
IOSP	-0.865
NOVT	-0.861

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Corcept Therapeutics Inc Correlation - Currency/Commodity

-0.12
( neutral )

-0.20
( neutral )

0.00
( neutral )

0.44
( neutral )

0.29
( neutral )

Corcept Therapeutics Inc Financials

Annual	2023
Revenue:	$482.38M
Gross Profit:	$475.89M (98.66 %)
EPS:	$1.020

Q4	2023
Revenue:	$135.41M
Gross Profit:	$133.53M (98.61 %)
EPS:	$0.300

Q3	2023
Revenue:	$123.60M
Gross Profit:	$121.96M (98.67 %)
EPS:	$0.310

Q2	2023
Revenue:	$117.72M
Gross Profit:	$116.14M (98.66 %)
EPS:	$0.270

Financial Reports:

No articles found.

Corcept Therapeutics Inc

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.